High-performance invasive brain-computer interface nears clinical validation stage

Beinao-2 (The NeuCyber Array BCI System), a high-performance invasive intelligent brain-computer interface (BCI) system, is expected to enter the clinical validation phase next year, said Li Yuan, business development director of Neucyber Neurotech (Beijing) Co Ltd, on Thursday.

Unlike Beinao-1 (The NeuCyber Matrix BCI System), Beinao-2 enables 3D spatial and multi-dimensional fine neural control. By leveraging high-throughput flexible microelectrode arrays to capture large-scale neuronal firing signals within the cerebral cortex, it focuses on achieving dynamic precision motor control, cognitive restoration and enhancement, full-body navigational motion control, and visual reconstruction and enhancement.